Back to search

France· FR:61952274

DUOPLAVIN 75 mg/75 mg, comprimé pelliculé

A medicinal product containing acide acétylsalicylique + clopidogrel (hydrogénosulfate de), registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDUOPLAVIN 75 mg/75 mg, comprimé pelli…ATC—REGISTER NO.FR:61952274PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACIDE ACÉTYLSALICYLIQUE + CLOPIDOGREL (HYDROGÉNOSULFATE DE)
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400938206371
    plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)
    EUR 8.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acide acétylsalicylique + clopidogrel (hydrogénosulfate de) in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acide acétylsalicylique + clopidogrel (hydrogénosulfate de) products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Bulgaria · Клопидогрел/Ацетилсалицилова Киселина Msn, Плакекс Комби
  • Czechia · Qydaxer Duo
  • Germany · Clopidogrel/Acetylsalicylsäure Vivanta
  • Estonia · Clopidogrel/Acetylsalicylic Acid Msn
  • Spain · Clopidogrel/Ácido Acetilsalicílico Vivanta
  • Hungary · Clopidogrel/Acetylsalicylic Acid Msn
  • Iceland · Clopidogrel/Acetylsalicylic Acid Doc, Clopidogrel/Acetylsalicylic Acid Msn Labs Europe Limited
  • Italy · Clopidogrel E Acido Acetilsalicilico Aurobindo, Clopidogrel E Acido Acetilsalicilico Doc
  • Liechtenstein · Clopidogrel/Acetylsalicylic Acid Viatris, Duoplavin
  • Lithuania · Clopidogrel/Acetylsalicylic Acid Msn
  • Latvia · Clopidogrel/Acetylsalicylic Acid Msn
  • Norway · Clopidogrel/Acetylsalicylic Acid Viatris, Duoplavin
  • Poland · Auroclasa, Clopidogrel/Acetylsalicylic Acid Msn
  • Portugal · Auroclasa, Clopidogrel + Ácido Acetilsalicílico Generis
  • Romania · Clopidogrel/Acid Acetilsalicilic Msn
  • Slovakia · Clopidogrel/Acetylsalicylic Acid Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6bd8763-79ae-4002-869b-6e8b69b5504f
GET /v1/drugs/c6bd8763-79ae-4002-869b-6e8b69b5504f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61952274",
  "date_amm": "2010-03-15",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/10/619",
  "substance": "ACIDE ACÉTYLSALICYLIQUE + CLOPIDOGREL (HYDROGÉNOSULFATE DE)",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about acide acétylsalicylique + clopidogrel (hydrogénosulfate de).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.